Presynaptic imidazoline receptors and α2-adrenoceptors in the human heart: Discrimination by clonidine and moxonidine

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 5, 1996, Pages 689-692

  Likungu, J ^a   Molderings, G J ^b   Gothert M ^b  

^a Klin F Herz Gefaßchirurgie   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

2 Adrenoceptor; Clonidine; Human atrium; Imidazoline receptor; Moxonidine

Indexed keywords

4 CHLORO 2 (2 IMIDAZOLIN 2 YLAMINO)ISOINDOLINE; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; IMIDAZOLINE RECEPTOR; MOXONIDINE; PRESYNAPTIC RECEPTOR; RAUWOLSCINE;

ARTICLE; CONCENTRATION RESPONSE; FEMALE; HEART ATRIUM; HUMAN; HUMAN TISSUE; MALE; NORADRENALIN RELEASE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HEART ATRIA; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG; YOHIMBINE;

EID: 0029860402     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Docherty JR, Göthert M, Dieckhöfer C, Starke K (1982) Effects of 4-chloro-2-(2-imidazolin-2-ylamino)-isoindoline hydrochloride (BE 6143) at pre- and postsynaptic α-adrenoceptors in rabbit aorta and pulmonary artery. Arzneimittelforsch 32: 1534-1540
2. 1-imidazoline receptors. J Cardiovasc Pharmacol 20 [Suppl 4]: S1-S10
3. 2-adrenoceptors and putative imidazoline receptors on rabbit heart sympathic nerves. Naunyn-Schmiedeberg's Arch Pharmacol 348: 127-133
4. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In. Blaschko H, Muscholl E (eds) Handbook of experimental pharmacology. Catecholamines, vol XXXIII. Springer, Berlin Heidelberg New York, pp 283-335
5. 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives. Naunyn-Schmiedeberg's Arch Pharmacol 343: 271-282
6. 2-Adrenoceptor-independent inhibition by imidazolines and guanidines of noradrenaline release from peripheral, but not central noradrenergic neurones. Ann NY Acad Sci 763: 405-419
7. 1-imidazoline agonist moxonidine administered into the rostral ventrolateral medulla. J Cardiovasc Pharmacol 20 [Suppl 4]: S11-S15
8. Molderings GJ, Hentrich F, Göthert M (1991) Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 344: 630-638
9. 2-imidazoline binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 351: 507-516
10. 1 receptor specific agent. J Med Chem 39: 1193-1195
11. Rump LC, Riera-Knorrenschild G, Schwertfeger E, Bohmann C, Spillner G, Schollmeyer P (1995a) Dopaminergic and α-adrenergic control of neurotransmission in human right atrium. J Cardiovasc Pharmacol 26: 462-470
12. 2C-Adrenoceptor-modulated release of noradrenaline in human right atrium. Br J Pharmacol 116: 2617-2624
13. 2-autoreceptors are involved in the blood pressure-lowering effect of moxonidine. J Cardiovasc Pharmacol 16: 15-22
14. Starke K (1977) Regulation of noradrenalline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77: 1-124
15. Starke K (1987) Presynaptic α-autoreceptors. Rev Physiol Biochem Pharmacol 107: 73-146
16. 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig. Pharmacol Toxicol 76: 353-364